Advertisement
Home 2017 March

Monthly Archives: March 2017

The intravenous drug Ocrevus (ocrelizumab) has been approved by the U.S. Food and Drug Administration to treat adults with primary progressive multiple sclerosis and relapsing forms of the disease

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

First drug sanctioned in United States for primary progressive multiple sclerosis
The causal links between Zika virus infection

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly
Exposure to the quadrivalent human papillomavirus vaccine during pregnancy is not associated with adverse pregnancy outcomes

Inadvertent HPV Vax Doesn’t Up Risk of Poor Pregnancy Outcomes

No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA
Individuals with hepatitis B and hepatitis C have increased rates of subsequent Parkinson's disease

Hepatitis B, C Linked to Higher Subsequent Rates of Parkinson’s

Increased rates of subsequent Parkinson's for those with hepatitis B, C, but not autoimmune hepatitis
Spending patterns in training hospital service areas impact physician spending

Spending Patterns in Training Influence Future Practice

Significant annual, per-beneficiary spending difference for physicians trained in high- and low-cost HSAs
Dupixent (dupilumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe eczema that isn't well controlled by topical medication.

FDA Approves Dupixent to Treat Eczema

Active ingredient binds to protein (interleukin-4 receptor alpha subunit) that causes inflammation
For patients with high-cervical spinal cord injury

Arm, Hand Function Restored in Tetraplegic Patient

Researchers utilized functional electric stimulation + intracortical brain-computer interface system
Total knee replacement has minimal effects on quality of life

Total Knee Replacement Typically Has Minimal Impact on QoL

Cost-effectiveness of the procedure could increase if restricted to more severely affected patients
In a position paper published online March 28 in the Annals of Internal Medicine

Substance Abuse Is a Treatable Chronic Medical Condition

ACP position paper outlines health and public policy interventions for effective prevention and treatment
For adults age 60+ years

Alcohol Consumption Trending Upward Among Older Adults

Among women age 60+, trend upward in prevalence of current drinking, binge drinking